Congestion Relief and Pitolisant
Determining the interaction of Congestion Relief and Pitolisant and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Concomitant use of pitolisant with NSAIDs and/or corticosteroids may increase the risk of gastrointestinal adverse effects such as dyspepsia, abdominal pain or discomfort, and gastritis due to potential additive irritant effects on the gastrointestinal mucosa. Clinical studies with pitolisant reported gastric disorders caused by hyperacidity in 3.5% of patients. However, the effects were described as mostly mild to moderate in severity. Data are not available on the potential for serious gastrointestinal (GI) toxicity, including inflammation, bleeding, ulceration, and perforation. MANAGEMENT: Caution is advised if pitolisant is used in combination with NSAIDs and/or corticosteroids, particularly in patients with a prior history of peptic ulcer disease or GI bleeding and in elderly or debilitated patients. If concomitant therapy is required, patients should be advised to report signs and symptoms of adverse GI effects, including abdominal pain or discomfort, dyspepsia, gastroesophageal reflux disease, gastritis, or the appearance of black, tarry stools. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Professional:MONITOR: Concomitant use of pitolisant with NSAIDs and/or corticosteroids may increase the risk of gastrointestinal adverse effects such as dyspepsia, abdominal pain or discomfort, and gastritis due to potential additive irritant effects on the gastrointestinal mucosa. Clinical studies with pitolisant reported gastric disorders caused by hyperacidity in 3.5% of patients. However, the effects were described as mostly mild to moderate in severity. Data are not available on the potential for serious gastrointestinal (GI) toxicity, including inflammation, bleeding, ulceration, and perforation.
MANAGEMENT: Caution is advised if pitolisant is used in combination with NSAIDs and/or corticosteroids, particularly in patients with a prior history of peptic ulcer disease or GI bleeding and in elderly or debilitated patients. If concomitant therapy is required, patients should be advised to report signs and symptoms of adverse GI effects, including abdominal pain or discomfort, dyspepsia, gastroesophageal reflux disease, gastritis, or the appearance of black, tarry stools.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: ibuprofen / phenylephrine
Brand name: Advil Congestion Relief, Advil Sinus Congestion & Pain, Congestion Relief, Sudafed PE Head Congestion
Synonyms: Ibuprofen and Phenylephrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Congestion Relief-Pitolisant Hydrochloride
- Congestion Relief-Pitressin
- Congestion Relief-Pitressin Injection
- Congestion Relief-Pitressin Synthetic
- Congestion Relief-Placidyl
- Congestion Relief-Plan B
- Pitolisant-Conivaptan
- Pitolisant-Conivaptan Hydrochloride
- Pitolisant-Conivaptan Intravenous
- Pitolisant-Conjugated estrogens
- Pitolisant-Conjugated estrogens and bazedoxifene
- Pitolisant-Conjugated estrogens and medroxyprogesterone